Jiangsu Renshou Pharmaceutical

Jiangsu Renshou Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company based in Huaian, Jiangsu Province, specializing in the research, development, and manufacturing of treatments for liver and cardiovascular diseases. Established in 2002, the company is a wholly-owned subsidiary of Boya Biopharmaceutical, which is part of the China Resources Pharmaceutical Group. Its core product portfolio includes the Huju Yigan Capsule and Tablet, widely used for chronic hepatitis B, alongside other proprietary formulations for liver protection and heart health. Renshou Pharmaceutical operates modern, GMP-certified facilities and has previously collaborated on international licensing for innovative small molecule drug candidates. The company continues to serve the domestic market with a blend of traditional Chinese medicine and chemical pharmaceutical products.